# Lymphocytic interstitial non-HIV-related pneumonia in pediatrics: a case report

**Authors:** Andrea Dionelly Murillo Casas, Diana María Duarte Dorado, Manuela Olaya Hernández

PMC · DOI: 10.3389/fped.2023.1307607 · Frontiers in Pediatrics · 2024-01-16

## TL;DR

This case report describes a rare case of lymphocytic interstitial pneumonia in a child without HIV, highlighting genetic mutations and clinical features.

## Contribution

The paper presents a novel case of non-HIV-related LIP in pediatrics with genetic findings and clinical observations.

## Key findings

- The patient had LIP with HTLV-1 infection and required lobectomy.
- Genetic analysis revealed heterozygous mutations in SCNN1B, FCHO1, and IL7R.
- No autoimmune disease or immunological abnormalities were detected.

## Abstract

Lymphocytic interstitial pneumonia (LIP) in pediatric patients without human immunodeficiency virus (HIV) infection remains a poorly characterized and enigmatic disease. Immunological dysregulation, mutations in the COPA gene, and increased morbidity and mortality have been reported in these patients. We present a case of LIP in a pediatric patient without HIV infection. This patient was infected with human T-lymphotropic virus type 1 (HTLV-1) and required right lower lobectomy with pathological findings compatible with lymphocytic interstitial pneumonia. In addition, bronchiectasis, dermatological involvement, and malnutrition were documented. However, no autoimmune disease, polymyositis, myelopathy, or opportunistic infections were found. There were no abnormalities in cellular and humoral immunity. A genetic study identified heterozygous mutations in the SCNN1B, FCHO1, and IL7R genes using single exome sequencing of coding and splicing regions. Although these heterozygous variants are not reported to be aetiological for LIP or diagnostic for the patient's congenital immunodeficiency, we believe they are associated with the severe lung damage seen in the patient's case.

## Linked entities

- **Genes:** COPA (coat protein complex I subunit alpha) [NCBI Gene 1314], SCNN1B (sodium channel epithelial 1 subunit beta) [NCBI Gene 6338], FCHO1 (FCH and mu domain containing endocytic adaptor 1) [NCBI Gene 23149], IL7R (interleukin 7 receptor) [NCBI Gene 3575]
- **Diseases:** lymphocytic interstitial pneumonia (MONDO:0009537), HIV infection (MONDO:0005109), polymyositis (MONDO:0019127), bronchiectasis (MONDO:0004822), malnutrition (MONDO:0006873)

## Full-text entities

- **Genes:** COPA (coat protein complex I subunit alpha) [NCBI Gene 1314] {aka AIAISD, AIAISD1, AILJK, HEP-COP, alpha-COP}, CD8A (CD8 subunit alpha) [NCBI Gene 925] {aka CD8, CD8alpha, IMD116, Leu2, p32}, LRBA (LPS responsive beige-like anchor protein) [NCBI Gene 987] {aka BGL, CDC4L, CVID8, LAB300, LBA, uc.147}, CD4 (CD4 molecule) [NCBI Gene 920] {aka CD4mut, IMD79, Leu-3, OKT4D, T4}, FCHO1 (FCH and mu domain containing endocytic adaptor 1) [NCBI Gene 23149] {aka IMD76}, CTLA4 (cytotoxic T-lymphocyte associated protein 4) [NCBI Gene 1493] {aka ALPS5, CD, CD152, CELIAC3, CTLA-4, GRD4}, SCNN1G (sodium channel epithelial 1 subunit gamma) [NCBI Gene 6340] {aka BESC3, ENaCg, ENaCgamma, LDLS2, PHA1, PHA1B3}, STING1 (stimulator of interferon response cGAMP interactor 1) [NCBI Gene 340061] {aka ERIS, MITA, MPYS, NET23, SAVI, STING}, IL7R (interleukin 7 receptor) [NCBI Gene 3575] {aka CD127, CDW127, IL-7R-alpha, IL-7Ralpha, IL7RA, IL7Ralpha}, SCNN1B (sodium channel epithelial 1 subunit beta) [NCBI Gene 6338] {aka BESC1, ENaCb, ENaCbeta, LIDLS1, PHA1B2, SCNEB}, STAT3 (signal transducer and activator of transcription 3) [NCBI Gene 6774] {aka ADMIO, ADMIO1, APRF, HIES}
- **Diseases:** pulmonary tuberculosis (MESH:D014397), common variable immunodeficiency (MESH:D017074), pulmonary lymphoproliferative disorder (MESH:D008232), autoimmune and/or chronic inflammatory diseases (MESH:D019693), alpha1-antitrypsin deficiency (MESH:D019896), dysgammaglobulinemia (MESH:D004406), functional impairment (MESH:D003072), systemic lupus erythematosus (MESH:D008180), CF (MESH:D003550), skin involvement (MESH:D012871), pulmonary function impairment (OMIM:608852), congenital abnormalities (MESH:D000013), Liddle syndrome (MESH:D056929), PHA1 (MESH:D011546), pulmonary fibrosis (MESH:D011658), HIV (MESH:D015658), Chronic disease (MESH:D002908), aspiration (MESH:D011015), lung damage (MESH:D008171), follicular bronchiolitis (MESH:D001988), immunodeficiencies (MESH:D007153), fever (MESH:D005334), Type 76 autosomal recessive immunodeficiency (OMIM:615540), infection (MESH:D007239), pulmonary involvement (MESH:C566343), respiratory failure (MESH:D012131), hypoxemia (MESH:D000860), Growth retardation (MESH:D006130), fungal or tuberculous infection (MESH:D009181), Sjogren's syndrome (MESH:D012859), pneumonia (MESH:D011014), IB (MESH:D001987), polymyositis (MESH:D017285), GLILD (MESH:D017563), nodular lymphoid hyperplasia (MESH:D020518), rheumatoid arthritis (MESH:D001172), fibrosis (MESH:D005355), congenital immunodeficiency (MESH:D000081207), damage to pulmonary function (MESH:D055370), viral infections (MESH:D014777), respiratory symptoms (MESH:D012818), malignancy (MESH:D009369), dyspnea (MESH:D004417), Immunological dysregulation (MESH:D007154), post-infectious disease (MESH:D000094025), opportunistic diseases (MESH:D009894), NK lymphopenia (MESH:D008231), lymphoma (MESH:D008223), cough (MESH:D003371), bronchial dilatation (MESH:D001982), Septal thickening (MESH:D013585), immune dysregulation (OMIM:614878), malnutrition (MESH:D044342), myelopathy (MESH:D013118), muscle atrophy (MESH:D009133), SCID (MESH:D016511), ciliary abnormalities (MESH:D002925), cyanosis (MESH:D003490), autoimmune disease (MESH:D001327)
- **Species:** Mycobacterium tuberculosis (species) [taxon 1773], Haemophilus influenzae (species) [taxon 727], Homo sapiens (human, species) [taxon 9606], Human immunodeficiency virus 1 (no rank) [taxon 11676], Human T-cell leukemia virus type I (no rank) [taxon 11908], human gammaherpesvirus 4 (Epstein Barr virus, no rank) [taxon 10376], Aspergillus (genus) [taxon 5052]
- **Mutations:** p.Gly341Glu, c.2401G>A, p.Arg669Cys

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC10829092/full.md

## Figures

3 figures with captions in the complete paper: https://tomesphere.com/paper/PMC10829092/full.md

## References

36 references — full list in the complete paper: https://tomesphere.com/paper/PMC10829092/full.md

---
Source: https://tomesphere.com/paper/PMC10829092